Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia : A collaborativemeta-analysis of contemporary randomized clinical trials

JAMA Internal Medicine

Volumn 174, Issue 2, 2014, Pages 232-240

  Stergiopoulos, Kathleen ^a   Boden, William E ^b   Hartigan, Pamela ^c   Möbius Winkler, Sven ^d   Hambrecht, Rainer ^e   Hueb, Whady ^f   Hardison, Regina M ^g   Abbott, J Dawn ^h   Brown, David L ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b ALBANY MEDICAL CENTER   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Klinikum Links der Weser gGmbH   (Germany)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGINA PECTORIS; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DEATH; DRUG ELUTING STENT; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MEDLINE; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

CORONARY STENOSIS; HUMANS; MYOCARDIAL ISCHEMIA; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84893590803     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.12855     Document Type: Article

References (43)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
2. Steg PG, Bhatt DL, Wilson PW, et al; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297(11):1197-1206.
3. Tardif J-C. Coronary artery disease in 2010. Eur Heart J Suppl. 2010;12(suppl C):C2-C10.
4. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107(23):2900-2907.
5. Marwick TH, Case C, Poldermans D, et al. A clinical and echocardiographic score for assigning risk of major events after dobutamine echocardiograms. J AmColl Cardiol. 2004;43(11):2102-2107.
6. Marwick TH, Case C, Sawada S, et al. Prediction of mortality using dobutamine echocardiography. J AmColl Cardiol. 2001;37(3):754-760.
7. Marwick TH, Case C, Vasey C, Allen S, Short L, Thomas JD. Prediction of mortality by exercise echocardiography: a strategy for combination with the duke treadmill score. Circulation. 2001;103(21):2566-2571.
8. Pijls NH, Sels JW. Functional measurement of coronary stenosis. J AmColl Cardiol. 2012;59(12):1045-1057.
9. Tonino PA, De Bruyne B, Pijls NH, et al; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213-224.
10. Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334(26):1703-1708.
11. Shaw LJ, Berman DS, Maron DJ, et al COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283-1291.
12. Shaw LJ,WeintraubWS, Maron DJ, et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J. 2012;164(2):243-250.
13. HuebW, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115(9):1082-1089.
14. Frye RL, August P, Brooks MM, et al; BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503-2515.
15. Hambrecht R,Walther C, Möbius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004;109(11):1371- 1378.
16. De Bruyne B, Pijls NH, Kalesan B, et al; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11):991-1001.
17. Boden WE, O'Rourke RA, Teo KK, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-1516.
18. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
19. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65-W94.
20. Brown KA, Boucher CA, Okada RD, et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J AmColl Cardiol. 1983;1(4):994-1001.
21. LadenheimML, Pollock BH, Rozanski A, et al. Extent and severity ofmyocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J AmColl Cardiol. 1986;7(3):464-471.
22. Shaw LJ, Peterson ED, Shaw LK, et al. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation. 1998;98(16):1622-1630.
23. Staniloff HM, Forrester JS, Berman DS, Swan HJ. Prediction of death, myocardial infarction, and worsening chest pain using thallium scintigraphy and exercise electrocardiography. J Nucl Med. 1986;27(12):1842-1848.
24. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value ofmyocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97(6):535-543.
25. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99msestamibi myocardial perfusion single-photon emission computed tomography. J AmColl Cardiol. 1995;26(3):639-647.
26. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93(5):905-914.
27. Dorbala S, Di Carli MF, Beanlands RS, et al. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J AmColl Cardiol. 2013;61(2):176-184.
28. WijnsW, Kolh P, Danchin N, et al; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501-2555.
29. Levine GN, Bates ER, Blankenship JC, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J AmColl Cardiol. 2011;58(24):e44-e122.
30. Fihn SD, Gardin JM, Abrams J, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J AmColl Cardiol. 2012;60(24):e44-e164.
31. Zellweger MJ, Pfisterer ME. Therapeutic strategies in patientswith chronic stable coronary artery disease. Cardiovasc Ther. 2011;29(6):e23-e30.
32. Pfisterer ME, Zellweger MJ, Gersh BJ. Management of stable coronary artery disease. Lancet. 2010;375(9716):763-772.
33. Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172(4):312-319.
34. Stukel TA, Fisher ES,Wennberg DE. Using observational data to estimate treatment effects. JAMA. 2007;297(19):2078-2079.
35. Fearon WF. Is amyocardial infarction more likely to result from a mild coronary lesion or an ischemia-producing one? Circ Cardiovasc Interv. 2011;4(6):539-541.
36. Schenker MP, Dorbala S, Hong EC, et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/ computed tomography study. Circulation. 2008;117(13):1693-1700.
37. LittleWC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78(5 Pt 1):1157-1166.
38. Pursnani S, Korley F, Gopaul R, et al. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials. Circ Cardiovasc Interv. 2012;5(4):476-490.
39. Thomas S, Gokhale R, Boden WE, Devereaux PJ. Ameta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris. Can J Cardiol. 2012;29(4):472-482.
40. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: ameta-analysis. Circulation. 2005;111(22):2906-2912.
41. Marzilli M, Merz CN, Boden WE, et al. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J AmColl Cardiol. 2012;60(11):951-956.
42. Califf RM. The trouble with ischemia. Am Heart J. 2012;164(2):133-134.
43. Hendel RC, BudoffMJ, Cardella JF, et al. ACC/AHA/ACR/ASE/ASNC/HRS/NASCI/ RSNA/SAIP/ SCAI/SCCT/SCMR/SIR 2008 key data elements and definitions for cardiac imaging: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Cardiac Imaging). Circulation. 2009;119(1):154-186.